Domenico Palli

ORCID: 0000-0002-5558-2437 · 4 papers in corpus
other 2019
Predicting Circulating CA125 Levels among Healthy Premenopausal Women
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.EPI-18-1120

BACKGROUND: Cancer antigen 125 (CA125) is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, thi…

review 2019
The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis
Critical reviews in oncology/hematology ·doi:10.1016/j.critrevonc.2018.12.009

We conducted a meta-analysis of studies reporting on the risk of extra-ovarian malignancies among women with endometriosis. Summary relative risk (SRR) and 95% confidence intervals (CI) were calculated through random effect models. We explo…

2016
Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort.
International journal of cancer ·doi:10.1002/ijc.29853

Acrylamide, classified in 1994 by IARC as "probably carcinogenic to humans," was discovered in 2002 in some heat-treated, carbohydrate-rich foods. Four prospective studies have evaluated the association between dietary acrylamide intake and…

2015
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.
British journal of cancer ·doi:10.1038/bjc.2015.22

BackgroundOvarian cancer has a high case-fatality ratio, largely due to late diagnosis. Epidemiologic risk prediction models could help identify women at increased risk who may benefit from targeted prevention measures, such as screening or…